In a pair of related studies, a team of Yale researchers has found a way to reverse type-2 diabetes and liver fibrosis in mice, and has shown that the underlying processes are conserved in humans.
The studies appear in the Feb. 4 edition of Cell Reports and in the Jan. 17 edition of Nature Communications.
In the earlier study, researchers found an important connection between how the body responds to fasting and type-2 diabetes. Fasting “switches on” a process in the body in which two particular proteins, TET3 and HNF4a, increase in the liver, driving up production of blood glucose. In type-2 diabetes, this “switch” fails to turn off when fasting ends, as it would in a non-diabetic person.
Researchers hypothesized that if they could “knock down” the levels of these two proteins, they could stop diabetes from developing. Yingqun Huang, M.D., Yale associate professor in Obstetrics, Gynecology, and Reproductive Sciences and her team injected mice with genetic material known as small interfering RNAs (siRNAs) packaged inside viruses that targeted TET3 or HNF4a. They found that blood glucose and insulin dropped significantly — effectively stopping diabetes in its tracks.
In the Feb. 4 Cell Reports study, researchers looked at how TET3 contributed to the development of fibrosis in the liver, and found that the protein was involved in fibrosis on multiple levels. Almost all fibrosis, regardless of the organ involved, starts from abnormal protein signaling, Huang said.
She and colleagues discovered that TET3 plays a role in the fibrosis signaling pathway in three different locations — and acts as an important regulator in fibrosis development. This means there are likely opportunities to develop drugs that inhibit TET3 to slow or reverse fibrosis, said Da Li, associate research scientist in genetics and co-author on both studies.
Both diseases — type-2 diabetes and fibrosis of the liver and other organs — are common, but have few treatment options. Around 28 million people in the U.S. have type-2 diabetes, characterized by high blood sugar levels, a condition that can lead to many other health problems, including heart disease, stroke, and kidney failure.
Cirrhosis is one of the leading causes of death worldwide and is marked by liver fibrosis — a buildup of scar tissue on the liver, said co-author James Boyer, M.D., professor and emeritus director of the Yale Liver Center.
Researchers noted that several drugs, such as metformin, are currently available to control blood sugar levels in patients with diabetes. But these have a range of unpleasant side effects, and patients can develop resistance to these drugs.
And there is little medical relief for fibrosis sufferers.
“Right now, there are no effective drugs for the treatment of fibrosis,” said Xuchen Zhang, M.D., associate professor in pathology and co-author on the fibrosis study.
Huang has filed for a patent related to her discoveries with support from the Yale Office of Cooperative Research.
The next step, she said, will be to identify where to best target TET3 and HNF4a and to develop the most effective siRNAs or small molecules to treat type-2 diabetes or fibrosis.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Reversing type-2 diabetes and liver fibrosis
- Is Fatty Liver Hereditary?
type 2 diabetes, or obesity. If you’re concerned about your symptoms and think you may have fatty liver disease, consider speaking with a doctor. They can provide a diagnosis and, if needed ...
- Specific class of drugs can reverse diet-induced obesity, fatty liver and diabetes in mice
Researchers at Karolinska Institutet may have found a new way to treat obesity and related disorders by targeting the cells' powerhouses, the mitochondria.
- Type 2 Diabetes: Etiology and Reversibility
In reverse order, the same mechanisms are likely to determine the events leading to the onset of hyperglycemia and permit insight into the etiology of type 2 diabetes. Within 7 days of instituting ...
- Insulin Resistance – What You Need to Know
Insulin resistance is when cells in your muscles, fat, and liver don’t ... not high enough for diabetes. Insulin resistance and prediabetes can both lead to type 2 diabetes.
- Lack of sleep could be a factor in a ‘silent epidemic,’ shares the same effects of alcoholism: expert
As its name implies, NAFLD is marked by the presence of fat in the liver. The primary cause is weight gain, along with metabolic risk factors such as type 2 diabetes, high blood pressure ...
Go deeper with Google Headlines on:
Reversing type-2 diabetes and liver fibrosis
[google_news title=”” keyword=”reversing type-2 diabetes and liver fibrosis” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Type-2 diabetes and liver fibrosis
- Do sex differences in how adipose tissue responds to insulin explain why type 2 diabetes is more common in men?
New research presented at the European Congress on Obesity (ECO) in Venice, Italy (12–15 May), and published in the International Journal of Obesity, could help explain why type 2 diabetes is more ...
- Diabetes News
A team of researchers has now been able to show in mice that adaptations in the liver mitochondria take place after only a few ... Genetics Predict Type 2 Diabetes Risk and Disparities in ...
- Madrigal Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
On March 14, 2024, received U.S. FDA approval of Rezdiffra™ (resmetirom) for the treatment of patients with noncirrhotic nonalcoholic ...
- Ancient Grains Like Oats and Millet Can Help People with Type 2 Diabetes Improve Heart Health
A new review showed ancient grains can improve cholesterol levels in people with type 2 diabetes. Aside from incorporating more ancient grains in your diet, experts recommend portion control, and ...
- Liver Disease News
Diabetes and Liver Cancer: Study Suggests New Screening Guidelines Feb. 1, 2024 — A new study identifies an easily measured biophysical property that can identify Type 2 diabetics at increased ...
Go deeper with Google Headlines on:
Type-2 diabetes and liver fibrosis
[google_news title=”” keyword=”type-2 diabetes and liver fibrosis” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]